Healthcare -
Biotechnology - NASDAQ - US
$ 1.93
-2.53 %
$ 69.7 M
Market Cap
-0.44
P/E
INO - OPERATING EXPENSES
Operating Expenses INO - Inovio Pharmaceuticals, Inc.
145 M
LAST VALUE
-30.88%
2 YEAR CAGR
3.05%
5 YEAR CAGR
15.25%
10 YEAR CAGR